tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

CNTX Stock Latest News

Context Therapeutics Secures Funding for Cancer Therapy Pipeline
Company AnnouncementsContext Therapeutics Secures Funding for Cancer Therapy Pipeline
19d ago
8K
CNTX
Context Therapeutics initiated with a Buy at D. Boral Capital
PremiumThe Fly
Context Therapeutics initiated with a Buy at D. Boral Capital
27d ago
CNTX
Context Therapeutics: Strategic Developments and Financial Outlook
PremiumCompany Announcements
Context Therapeutics: Strategic Developments and Financial Outlook
30d ago
CNTX
Context Therapeutics files $250M mixed securities shelf
PremiumThe Fly
Context Therapeutics files $250M mixed securities shelf
2M ago
CNTX
Context Therapeutics management to meet with Maxim
PremiumThe Fly
Context Therapeutics management to meet with Maxim
2M ago
CNTX
Context Therapeutics management to meet with Piper Sandler
PremiumThe FlyContext Therapeutics management to meet with Piper Sandler
3M ago
CNTX
Context Therapeutics Acquires Rights to Innovate Cancer Antibodies
Premium
Company Announcements
Context Therapeutics Acquires Rights to Innovate Cancer Antibodies
3M ago
8K
CNTX
BioAtla, Context Therapeutics enter exclusive license agreement for BA3362
Premium
The Fly
BioAtla, Context Therapeutics enter exclusive license agreement for BA3362
3M ago
BCAB
CNTX
Context Therapeutics Bolsters Board with Industry Veterans
PremiumCompany Announcements
Context Therapeutics Bolsters Board with Industry Veterans
4M ago
8K
CNTX
Context Therapeutics appoints Smith, Walker to board of directors
PremiumThe Fly
Context Therapeutics appoints Smith, Walker to board of directors
4M ago
CNTX
Context appoints Ultmann as CMO, Andreas as VP of Clinical Operations
PremiumThe Fly
Context appoints Ultmann as CMO, Andreas as VP of Clinical Operations
5M ago
CNTX
Context Therapeutics Acquires CT-95 for Cancer Trial Launch
PremiumCompany Announcements
Context Therapeutics Acquires CT-95 for Cancer Trial Launch
5M ago
8K
CNTX
Context Therapeutics acquires Phase 1-ready T cell engager CT-95
PremiumThe FlyContext Therapeutics acquires Phase 1-ready T cell engager CT-95
5M ago
CNTX
Context Therapeutics files to sell 64.52M shares of common stock for holders
Premium
The Fly
Context Therapeutics files to sell 64.52M shares of common stock for holders
7M ago
CNTX
Context Therapeutics initiated with an Overweight at Piper Sandler
Premium
The Fly
Context Therapeutics initiated with an Overweight at Piper Sandler
7M ago
CNTX
Context Therapeutics price target raised to $10 from $4 at Maxim
PremiumThe Fly
Context Therapeutics price target raised to $10 from $4 at Maxim
8M ago
CNTX
Context Therapeutics Secures Funding, Advances Clinical Trials
PremiumCompany Announcements
Context Therapeutics Secures Funding, Advances Clinical Trials
8M ago
8K
CNTX
Context Therapeutics to sell 64.5M shares at $1.55 in private placement
PremiumThe Fly
Context Therapeutics to sell 64.5M shares at $1.55 in private placement
8M ago
CNTX
Context announces FDA clearance of IND application for Phase 1 trial of CTIM-76
PremiumThe Fly
Context announces FDA clearance of IND application for Phase 1 trial of CTIM-76
8M ago
CNTX
Context Therapeutics Advances Cancer Trial with FDA Submission
PremiumCompany AnnouncementsContext Therapeutics Advances Cancer Trial with FDA Submission
9M ago
8K
CNTX
Context Therapeutics submits IND application for CTIM-76
Premium
The Fly
Context Therapeutics submits IND application for CTIM-76
9M ago
CNTX
Context Therapeutics expects cash to fund operations into late 2024
Premium
The Fly
Context Therapeutics expects cash to fund operations into late 2024
9M ago
CNTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >